Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;6(4):309-15.
doi: 10.4161/21505594.2014.983015. Epub 2015 Jan 6.

Vaccines in the treatment of invasive candidiasis

Xiao-juan Wang  1 , Xue Sui, Lan Yan, Yan Wang, Yong-bing Cao, Yuan-ying Jiang
Affiliations
Review

Vaccines in the treatment of invasive candidiasis

Xiao-juan Wang et al. Virulence. 2015.

Abstract

Candida albicans is the most common cause of hematogenously disseminated candidiasis, and this disease is particularly prevalent in immunocompromised patients. The mortality of invasive candidiasis remains 40% to 50% even with the proper treatment with current antifungal drugs. Recently, with the better understanding of host-fungus interactions, notable progress has been made in antifungal vaccine research. Most antifungal vaccines exert protection by inducing either (or both) B-cell and T-cell responses. Here we summarize the current available information on C. albicans vaccines, highlight the obstacles that researchers identified, and offer several suggestions.

Keywords: Candida albicans; immune response; invasive candidiasis; vaccine; virulence.

PubMed Disclaimer

References

    1. Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH. An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov 2010; 9:719-27; PMID:20725094; http://dx.doi.org/ 10.1038/nrd3074 - DOI - PubMed
    1. Liao Y, Chen M, Hartmann T, Yang RY, Liao WQ. Epidemiology of opportunistic invasive fungal infections in China: review of literature. Chin Med J (Engl) 2013; 126:361-8; PMID:23324290 - PubMed
    1. Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4:1-23; PMID:14661066 - PubMed
    1. Garcia-Vidal C, Viasus D, Carratala J. Pathogenesis of invasive fungal infections. Curr Opin Infect Dis 2013; 26:270-6; PMID:23449139; http://dx.doi.org/ 10.1097/QCO.0b013e32835fb920 - DOI - PubMed
    1. Dan JM, Levitz SM. Prospects for development of vaccines against fungal diseases. Drug Resist Updat 2006; 9:105-10; PMID:16820318; http://dx.doi.org/ 10.1016/j.drup.2006.05.004 - DOI - PubMed

Publication types